Aldo‐keto reductase family 1 member C1 (AKR1C1) was identified as a potential therapeutic target and demonstrated the inhibitory effect of aspirin and dydrogesterone as its inhibitors on tumor cells. The gene discussed is AKR1C1; the disease is neoplasm.